Commercial Operations Contract Analyst at HeartFlow

San Francisco, California, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Medical Technology, HealthcareIndustries

Requirements

Experience analyzing data and the ability to use data to drive insights and decision-making; strong quantitative analysis skills
Basic to expert knowledge of core contracting concepts, including the Uniform Commercial Code (UCC), and applicable international or public contract law and regulations
Comfortable presenting to and partnering with executives to solve complex business challenges
Strong communication skills for internal and external negotiation and collaboration
Ability to draft clear, concise, and non-ambiguous contractual language
Skill in managing the contract redlining process, including using track changes or redlining tools and adding comments to explain revisions
Knowledge of best practices for maintaining clean version control throughout the negotiation process

Responsibilities

Drafting, reviewing, and redlining a variety of contractual instruments, which may range from simple to moderate complexity
Analyzing contract requirements, special provisions, and terms and conditions to ensure compliance with relevant laws, regulations, and corporate policies and procedures
Providing contractual guidance to business team members (including sales) to ensure terms are realistic for the company and align with business objectives before execution
Monitoring possible compliance issues and ensuring that agreed-upon terms are executable by the company, including consulting with other internal departments (e.g., accounting)
Collaborating with sales/business teams on contract negotiations

Skills

Contract Analysis

Commercial Operations

Planning

Forecasting

Reporting

Commercial Strategy

Process Optimization

Program Implementation

Compensation Design

HeartFlow

Non-invasive cardiac testing for heart disease

About HeartFlow

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries, including the United States, the United Kingdom, Japan, and Canada. Unlike many competitors, HeartFlow focuses on providing a comprehensive suite of analyses that enhance treatment planning. The goal of HeartFlow is to improve cardiovascular care by making it safer and more efficient for both patients and healthcare providers.

Redwood City, CaliforniaHeadquarters

2010Year Founded

$858.5MTotal Funding

SERIES_FCompany Stage

HealthcareIndustries

501-1,000Employees

Benefits

Remote Work Options

Stock Options

401(k) Company Match

Risks

Emerging AI-driven competitors could threaten HeartFlow's market share.

Algorithmic bias in AI models could lead to inaccurate diagnoses.

Integration into healthcare systems may face resistance due to complexity and cost.

Differentiation

HeartFlow offers the only combined anatomy, physiology, and plaque analysis for heart disease.

HeartFlow's non-invasive FFRCT Analysis is FDA-cleared and widely available globally.

HeartFlow's AI-driven technology provides personalized 3D heart models for precise diagnostics.

Upsides

HeartFlow closed a $215 million Series F funding round in April 2023.

The global non-invasive cardiac imaging market is projected to grow significantly.

HeartFlow's technology aligns with the trend towards value-based care in healthcare.

Land your dream remote job 3x faster with AI

Try Jobo Free